MARKET

BMRN

BMRN

BioMarin Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

79.60
-0.23
-0.29%
After Hours: 79.60 0 0.00% 17:13 04/08 EDT
OPEN
79.98
PREV CLOSE
79.83
HIGH
81.74
LOW
78.88
VOLUME
1.50M
TURNOVER
--
52 WEEK HIGH
97.10
52 WEEK LOW
62.88
MARKET CAP
14.32B
P/E (TTM)
-544.4596
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 25 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BMRN stock price target is 117.64 with a high estimate of 164.00 and a low estimate of 77.00.

EPS

BMRN News

More
  • Is BioMarin Pharmaceuticals Stock a Buy?
  • MotleyFool.com · 9h ago
  • Vertex Pharmaceuticals And BioMarin Pharmaceutical: 2 Safe Biotech Picks To Buy During This Bear Market
  • Seeking Alpha - Article · 1d ago
  • Biomarin to File Regulatory Applications for Vosoritide in Q3
  • Zacks · 1d ago
  • BioMarin readies vosoritide applications in U.S. and Europe
  • seekingalpha · 2d ago

Industry

Pharmaceuticals
+2.78%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About BMRN

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.
More

Webull offers kinds of BioMarin Pharmaceutical Inc. stock information, including NASDAQ:BMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRN stock news, and many more online research tools to help you make informed decisions.